Univariable and multivariable logistic regression analysis for occult N1 and N2 lymph node metastasis
| N1 lymph node metastasis . | N2 lymph node metastasis . | |||||||
|---|---|---|---|---|---|---|---|---|
| Variables . | Univariable . | Multivariable . | Univariable . | Multivariable . | ||||
| OR (95% CI) . | P-value . | OR (95% CI) . | P-value . | OR (95% CI) . | P-value . | OR (95% CI) . | P-value . | |
| Agea | 1.00 (0.97–1.03) | 0.983 | – | – | 0.97 (0.94–0.99) | 0.034 | 0.96 (0.94–0.99) | 0.019 |
| Sex (male/female) | 1.22 (0.72–1.40) | 0.470 | – | – | 1.58 (0.81–3.07) | 0.176 | – | – |
| Smoking history (yes/never) | 1.57 (0.88–2.80) | 0.124 | – | – | 1.38 (0.72–2.61) | 0.329 | – | – |
| Solid tumour size (mm)a | 1.28 (1.17–1.39) | <0.001 | 1.22 (1.12–1.35) | <0.001 | 1.15 (1.04–1.26) | 0.003 | – | – |
| Pure solid tumour (yes/no) | 6.07 (2.41–15.30) | <0.001 | – | – | 2.91 (1.21–7.01) | 0.017 | 2.50 (1.00–6.22) | 0.049 |
| SUVmaxa | 1.14 (1.09–1.20) | <0.001 | 1.10 (1.05–1.16) | <0.001 | 1.09 (1.03–1.15) | 0.005 | 1.07 (1.01–1.14) | 0.030 |
| Central/peripheral | 1.92 (1.11–3.31) | 0.019 | 1.91 (1.09–3.36) | 0.024 | 0.68 (0.30–1.56) | 0.363 | – | – |
| N1 lymph node metastasis . | N2 lymph node metastasis . | |||||||
|---|---|---|---|---|---|---|---|---|
| Variables . | Univariable . | Multivariable . | Univariable . | Multivariable . | ||||
| OR (95% CI) . | P-value . | OR (95% CI) . | P-value . | OR (95% CI) . | P-value . | OR (95% CI) . | P-value . | |
| Agea | 1.00 (0.97–1.03) | 0.983 | – | – | 0.97 (0.94–0.99) | 0.034 | 0.96 (0.94–0.99) | 0.019 |
| Sex (male/female) | 1.22 (0.72–1.40) | 0.470 | – | – | 1.58 (0.81–3.07) | 0.176 | – | – |
| Smoking history (yes/never) | 1.57 (0.88–2.80) | 0.124 | – | – | 1.38 (0.72–2.61) | 0.329 | – | – |
| Solid tumour size (mm)a | 1.28 (1.17–1.39) | <0.001 | 1.22 (1.12–1.35) | <0.001 | 1.15 (1.04–1.26) | 0.003 | – | – |
| Pure solid tumour (yes/no) | 6.07 (2.41–15.30) | <0.001 | – | – | 2.91 (1.21–7.01) | 0.017 | 2.50 (1.00–6.22) | 0.049 |
| SUVmaxa | 1.14 (1.09–1.20) | <0.001 | 1.10 (1.05–1.16) | <0.001 | 1.09 (1.03–1.15) | 0.005 | 1.07 (1.01–1.14) | 0.030 |
| Central/peripheral | 1.92 (1.11–3.31) | 0.019 | 1.91 (1.09–3.36) | 0.024 | 0.68 (0.30–1.56) | 0.363 | – | – |
Continuous value.
CI: confidence interval; OR: odds ratio; SUVmax: the maximum standard uptake value.
Univariable and multivariable logistic regression analysis for occult N1 and N2 lymph node metastasis
| N1 lymph node metastasis . | N2 lymph node metastasis . | |||||||
|---|---|---|---|---|---|---|---|---|
| Variables . | Univariable . | Multivariable . | Univariable . | Multivariable . | ||||
| OR (95% CI) . | P-value . | OR (95% CI) . | P-value . | OR (95% CI) . | P-value . | OR (95% CI) . | P-value . | |
| Agea | 1.00 (0.97–1.03) | 0.983 | – | – | 0.97 (0.94–0.99) | 0.034 | 0.96 (0.94–0.99) | 0.019 |
| Sex (male/female) | 1.22 (0.72–1.40) | 0.470 | – | – | 1.58 (0.81–3.07) | 0.176 | – | – |
| Smoking history (yes/never) | 1.57 (0.88–2.80) | 0.124 | – | – | 1.38 (0.72–2.61) | 0.329 | – | – |
| Solid tumour size (mm)a | 1.28 (1.17–1.39) | <0.001 | 1.22 (1.12–1.35) | <0.001 | 1.15 (1.04–1.26) | 0.003 | – | – |
| Pure solid tumour (yes/no) | 6.07 (2.41–15.30) | <0.001 | – | – | 2.91 (1.21–7.01) | 0.017 | 2.50 (1.00–6.22) | 0.049 |
| SUVmaxa | 1.14 (1.09–1.20) | <0.001 | 1.10 (1.05–1.16) | <0.001 | 1.09 (1.03–1.15) | 0.005 | 1.07 (1.01–1.14) | 0.030 |
| Central/peripheral | 1.92 (1.11–3.31) | 0.019 | 1.91 (1.09–3.36) | 0.024 | 0.68 (0.30–1.56) | 0.363 | – | – |
| N1 lymph node metastasis . | N2 lymph node metastasis . | |||||||
|---|---|---|---|---|---|---|---|---|
| Variables . | Univariable . | Multivariable . | Univariable . | Multivariable . | ||||
| OR (95% CI) . | P-value . | OR (95% CI) . | P-value . | OR (95% CI) . | P-value . | OR (95% CI) . | P-value . | |
| Agea | 1.00 (0.97–1.03) | 0.983 | – | – | 0.97 (0.94–0.99) | 0.034 | 0.96 (0.94–0.99) | 0.019 |
| Sex (male/female) | 1.22 (0.72–1.40) | 0.470 | – | – | 1.58 (0.81–3.07) | 0.176 | – | – |
| Smoking history (yes/never) | 1.57 (0.88–2.80) | 0.124 | – | – | 1.38 (0.72–2.61) | 0.329 | – | – |
| Solid tumour size (mm)a | 1.28 (1.17–1.39) | <0.001 | 1.22 (1.12–1.35) | <0.001 | 1.15 (1.04–1.26) | 0.003 | – | – |
| Pure solid tumour (yes/no) | 6.07 (2.41–15.30) | <0.001 | – | – | 2.91 (1.21–7.01) | 0.017 | 2.50 (1.00–6.22) | 0.049 |
| SUVmaxa | 1.14 (1.09–1.20) | <0.001 | 1.10 (1.05–1.16) | <0.001 | 1.09 (1.03–1.15) | 0.005 | 1.07 (1.01–1.14) | 0.030 |
| Central/peripheral | 1.92 (1.11–3.31) | 0.019 | 1.91 (1.09–3.36) | 0.024 | 0.68 (0.30–1.56) | 0.363 | – | – |
Continuous value.
CI: confidence interval; OR: odds ratio; SUVmax: the maximum standard uptake value.
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.
